Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 108INDUSTRY 84NETWORK 4NIH 2OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4Urothelial Cancer 1Pancreatic Adenocarcinoma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 17Fluorouracil 8Capecitabine 6Radiotherapy 5Leucovorin 5Albumin-Bound Paclitaxel 5Taxes 4Irinotecan 4Cisplatin 4130-nm albumin-bound paclitaxel 4Specimen Handling 3Radiotherapy, Conformal 3Docetaxel 3irinotecan sucrosofate 2dehydroftorafur 2Surgical Procedures, Operative 2Radiosurgery 2Pancreaticoduodenectomy 2Chemotherapy, Adjuvant 2Cetuximab 2trametinib 1tipifarnib 1saracatinib 1pegfilgrastim 1lanreotide 1ganitumab 1durvalumab 1conatumumab 1beta-D-glucosylisophosphoramide mustard 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Pancreatic Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT06998940 2026-05-22

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

SWOG Cancer Research Network

Phase 3 Recruiting
94 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04233866 2026-05-05

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
176 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04089150 2021-10-22

MASTERPLAN

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
120 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01921751 2018-07-13

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Radiation Therapy Oncology Group

Phase 2 Terminated
20 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡